Article

Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer Patients

2021-08-04

Abstract excerpt

<title>Abstract</title> <p>BackgroundHuman epidermal growth factor receptor 2 (HER2) low expressed breast cancer was considered as a distinct subtype different from HER2 negative tumors. We investigated the clinicopathological features and recurrence score (RS) of HER2-low and HER2- patients and their prognostic value in hormone receptor (HR) positive breast cancer.MethodsA total of 2,099 HR-positive primary fema...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bc12f4e3-cbed-555c-9785-cc3716ec5bb4
DOI: 10.21203/rs.3.rs-752911/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer PatientsDOI 10.21203/rs.3.rs-752911/v1Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

Molecular and clinical traits of HER2-low breast cancer patients and their relationship with neoadjuvant treatment effectiveness.Semantic proximity Read

[Biological characteristics of triple negative breast cancer with low expression of HER2].Semantic proximity Read

Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?Semantic proximity Read

Impact of HER2-low Breast Cancer on Survival in Denmark: A Nationwide Investigation (2007-2019)Semantic proximity Read

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other BiomarkersSemantic proximity Read

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerSemantic proximity Read

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusSemantic proximity Read

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.Semantic proximity Read

Genomic Alterations of Tumors in HER2-Low Breast Cancers.Semantic proximity Read

Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysisSemantic proximity Read

Deciphering HER2 Breast Cancer Disease: Biological and Clinical ImplicationsSemantic proximity Read